Moriya Iwaizumi Selected Research

11 alpha- hydroxy- 9,15- dioxo- 2,3,4,5,20- pentanor- 19- carboxyprostanoic acid

1/2022	Predicting Ulcerative Colitis Relapse in Clinical Remission With Fecal Immunochemical Occult Blood Test or Prostaglandin E-Major Urinary Metabolite.
10/2021	Comparison between Prostaglandin E-major urinary metabolite and C-reactive protein levels to reflect endoscopic scores in patients with ulcerative colitis.
12/2020	Prostaglandin E-Major Urinary Metabolite Predicts Relapse in Patients With Ulcerative Colitis in Clinical Remission.
4/2020	Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moriya Iwaizumi Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 11/2010
12	Ulcerative Colitis 01/2022 - 12/2018
10	Colorectal Neoplasms (Colorectal Cancer) 02/2018 - 11/2010
6	Crohn Disease (Crohn's Disease) 07/2021 - 01/2017
5	Stomach Neoplasms (Stomach Cancer) 08/2020 - 08/2009
4	Adenocarcinoma 09/2020 - 02/2009
3	Esophageal Neoplasms (Esophageal Cancer) 11/2020 - 11/2009
3	Esophageal Squamous Cell Carcinoma 11/2020 - 11/2009
2	Gastroesophageal Reflux (GERD) 07/2021 - 01/2018
2	Inflammation (Inflammations) 01/2021 - 12/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2017
2	Infections 01/2020 - 08/2014
2	Turcot syndrome 02/2018 - 01/2016
2	Lung Neoplasms (Lung Cancer) 09/2017 - 10/2013
1	Carcinoma (Carcinomatosis) 10/2021
1	Medullary Carcinoma 10/2021
1	Carcinoid Tumor (Carcinoid) 07/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Bone Resorption 01/2021
1	Tuberous Sclerosis (Bourneville's Disease) 12/2020
1	Neuroendocrine Carcinoma 12/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2020
1	Dizziness (Lightheadedness) 12/2020
1	Chromosomal Instability (Chromosome Stability) 09/2020
1	Disease Progression 07/2020
1	Carcinoma in Situ 05/2020
1	Esophageal Stenosis (Esophageal Stricture) 05/2020
1	Duodenal Neoplasms (Duodenal Cancer) 09/2017
1	Hemorrhage 04/2017
1	Wasting Syndrome (Wasting Disease) 01/2017
1	Heart Failure 01/2017
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017
1	Colitis 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Arthritis (Polyarthritis) 01/2017
1	Duodenal Ulcer (Curling's Ulcer) 04/2015
1	Barrett Esophagus (Barrett's Esophagus) 01/2014

Drug/Important Bio-Agent (IBA)

9	Fluorouracil (Carac)FDA LinkGeneric 02/2018 - 02/2009
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2009
7	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2018
6	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2010
5	C-Reactive ProteinIBA 01/2022 - 12/2020
4	ProstaglandinsIBA 01/2022 - 04/2020
4	11 alpha- hydroxy- 9,15- dioxo- 2,3,4,5,20- pentanor- 19- carboxyprostanoic acidIBA 01/2022 - 04/2020
3	nedaplatinIBA 11/2020 - 02/2009
3	Calcibiotic Root Canal SealerIBA 08/2015 - 01/2012
2	AlbuminsIBA 01/2022 - 12/2020
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 12/2020
2	Capsules (Microcapsules)IBA 07/2021 - 12/2018
2	Proton Pump InhibitorsIBA 07/2021 - 04/2017
2	AcidsIBA 07/2021 - 01/2018
2	Serum AlbuminIBA 06/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2017 - 08/2009
1	tofacitinibIBA 01/2022
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 07/2021
1	SteroidsIBA 06/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2021
1	benralizumabIBA 01/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021
1	Adalimumab (Humira)FDA Link 01/2021
1	Collagen Type I (Type I Collagen)IBA 01/2021
1	Mesalamine (Mesalazine)FDA LinkGeneric 12/2020
1	Delayed-Action PreparationsIBA 12/2020
1	TabletsIBA 12/2020
1	trans-sodium crocetinate (crocetin)IBA 12/2020
1	PlatinumIBA 11/2020
1	MutL Protein Homolog 1IBA 09/2020
1	MutS ProteinsIBA 09/2020
1	Infliximab (Remicade)FDA Link 07/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2020
1	Talaporfin (talaporfin sodium)IBA 05/2020
1	Anti-Infective Agents (Microbicides)IBA 01/2020
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 10/2018
1	Trifluridine (Viroptic)FDA LinkGeneric 02/2018
1	trifluridine tipiracil drug combinationIBA 02/2018
1	Antineoplastic Agents (Antineoplastics)IBA 02/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017
1	ErbB Receptors (EGF Receptor)IBA 09/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2017
1	RetinoidsIBA 01/2017
1	Digoxin (Digitek)FDA LinkGeneric 01/2017
1	Cardiac GlycosidesIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	CytokinesIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	AntigensIBA 04/2015
1	Cytochrome P-450 CYP2C19IBA 08/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014
1	Bile Acids and Salts (Bile Acids)IBA 01/2014

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2015
5	Drug Therapy (Chemotherapy) 02/2018 - 11/2009
4	Chemoradiotherapy 11/2020 - 02/2009
1	Colectomy 10/2021
1	Remission Induction 06/2021
1	Enterostomy 02/2021
1	Photochemotherapy (Photodynamic Therapy) 05/2020
1	Radiotherapy 05/2020
1	Salvage Therapy 05/2020